Serratia marcescens and other non-AACEK GNB endocarditis: A case report and review of literature

Table 1 Serratia marcescens endocarditis in adults since 1990

Ref.	Age (yr)	Risk factors	Acquisition	Treatment and duration (wk)	Valve surgery	Outcome (follow-up)
Ena et al[15], 1991	29	IVDU	CA	Ciprofloxacin (4 IV + 1 po)	Y	Survived (13 mo)
Körner et al[18], 1994	50	Lymphoma, chemotherapy, CVC	HCA	Azlocillin/gentamycin	N7	Survived (5 mo)
				(6 IV)
Baggish et al[19], 2007	43	Splenectomy	CA	Cefepime (6 IV) and gentamycin (2 IV)	Y	Survived (1 yr)
De Silva et al[20], 2009	67	ICD	CA	Meropenem and gentamycin (NM), then ciprofloxacin (2 po)	N (ICD extraction)	Survived (6 mo)
Hadano et al[16], 2012	85	Diabetes, corticosteroids	HCA	Ceftazidime (6 IV) and gentamycin (5 d)	N	Died
Lyall et al[17], 2013	65	Post-Bentall + coronary bypass surgery	HCA	Meropenem and ciprofloxacin and gentamycin (NM)	N	Survived
Phadke et al[12], 2016	46	IVDU, HIV	CA	Meropenem (NM)	N	Died
Meyer et al[21], 2018	42	IVDU	CA	Ceftriaxone (6 IV)	Y	Survived
Current case, 2018	46	ICD	HCA	Piperacillin-tazobactam IV and ciprofloxacin po (5), then ciprofloxacin and trimethoprim/sulfamethoxazole (3 po)	N (ICD extraction)	Survived (6 mo)

IVDU: Intravenous drug use; CA: Community acquired; IV: Intravenous; Y: Yes; CVC: Central venous catheter; HCA: Healthcare associated; N: No; NS: Not specified; ICD: Intracardiac device; NM: Not mentioned; po: Per os.